Publications for Danuta Kalinowski 2017

Potent Anti-Mycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analogue, 2- Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: A Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide

Novel Thiosemicarbazones Inhibit Lysine-Rich CEACAM1 Co-isolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-Regulated Gene 1 (NDRG1)

Affiliations: Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, China [R.X., X.Z]. Department of Applied Biology and Chemical Technology, the Hong Kong Polytechnic University, Hong Kong, China [I.H.Y.P.]. This article has not been copyedited and formatted. The final version may differ from this version. Molecular Pharmacology Fast Forward. Published o...

Contingency Factors Influencing Implementation of Physical Asset Management Practices

Iron Chelators of the DpT and BpT Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets – Iron, CDK2 and CDK9

Center for Sickle Cell Disease, Department of Medicine, Howard University, Washington DC (Z.D., T.A., D.B., V.R.G., S.N.); Department of Pharmaceutical Sciences, Howard University, Washington DC (Z.D., P.K.K., K.K); Department of Microbiology, Howard University, Washington DC (D.B., S.N.); Iron Metabolism and Chelation Program, Department of Pathology and Bosch Institute, University of Sydney, ...

The evolution of iron chelators for the treatment of iron overload disease and cancer.

The evolution of iron chelators from a range of primordial siderophores and aromatic heterocyclic ligands has lead to the formation of a new generation of potent and efficient iron chelators. For example, various siderophore analogs and synthetic ligands, including ICL670A [4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid], 4'-hydroxydesazadesferrithiocin, and Triapine, have been dev...